OpenAlex
PricingAboutJobs
Log inGet started
Work

A 14-Day Dose-Response Study of the Efficacy, Safety, and Pharmacokinetics of the Nonpeptidic Protease Inhibitor Tipranavir in Treatment-Naive HIV-1???Infected Patients

HTML

Year: 2004
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: JAIDS Journal of Acquired Immune Deficiency Syndromes
DOI: 10.1097/00126334-200404010-00007
Authors: Scott McCallister, Hernan Valdez, Kevin Curry, Thomas MacGregor, Marie Borin, William Freimuth, Yenyung Wang, Douglas L. Mayers
Institution: Boehringer Ingelheim (United States)
Language: English

Topic: HIV/AIDS drug development and treatment
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: tipranavir, HIV-1 infection, treatment-naive patients, ritonavir, self-emulsifying drug delivery systems, viral load reduction, pharmacokinetics, dose-response relationship, drug safety, antiretroviral therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2066735345
FWCI: 6.76
Cites: 11
Cited by: 52
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security